1. Building a Robust Supply Chain with Dependable Quality Primary Suppliers

    Drug manufacturers and their suppliers face a number of challenges, such as downward pricing pressures and the need for flexibility and speed to market, says Dale Martin, General Manager & CFO for CapsCanada.

  2. With Expertise Comes Security

    Using a trusted expert to remove surplus equipment helps protect your facility and assets, says Matt Hicks, Chief Operating Officer & Counsel for Federal Equipment Company. 

  3. Death to Cleanrooms in Biopharmaceutical Manufacturing

    Marc Pelletier, Ph.D., Director of CRB USA explains the benefits of closed processing.

  4. Biosimilars: Are We on the Edge of a New Era of Biologics?

    Experts weigh in on our Roundtable question.

  5. Nice Insight Overview: The Key to Pharma’s Next Generation Success

    Evolving markets are prompting drug owners and developers to pursue new business models in the post-blockbuster era.

  6. Behind the Scenes of International Pharmaceutical Business Success: A Conversation with Horst Wallrabe

    Haig Armaghanian is in conversation with Horst Wallrabe, formerly of Bayer, to reflect on his impressive career and what lies ahead.

  7. Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins

    The company received approval to relocate existing immunodiagnostic manufacturing operations to a new Consolidated Manufacturing Facility (CMF) in Emeryville, California. 

  8. Xolair Gets Breakthrough Therapy Designation from US FDA for Treatment of Food Allergies
    If approved, the drug would be the first FDA-approved treatment for the prevention of severe reactions due to food allergies.
  9. Perrigo to Divest Its Prescription Drug Business

    Company to focus on generics and consumer products.

  10. Array BioPharma Receives FDA Breakthrough Therapy Designation for BRAFTOVI™ in combination with MEKTOVI® and cetuximab for BRAFV600E-mutant Metastatic Colorectal Cancer

    The designation is based on Phase 3 BEACON CRC safety lead-in data.

  11. Focused on Fermentation

    Capua BioServices continues to invest to support modern fermentation, explains Elise Mous Director Sales & Marketing/Business Development and Thomas De Maria, Business Development Manager.

  12. Why Business Continuity Management is Important for CDMOs

    Mayeul Cauvin, Risk Management Department, Corporate Loss Prevention Manager for Servier CDMO explains the impact of Business Continuity Management.

  13. Supporting the Tech Transfer Continuum for Cell & Gene Therapies

    Thought leaders from Brammer Bio explain how to satisfy development and manufacturing needs of next generation therapies.

  14. Making Real-Time Process Analytical Technology In Biomanufacturing A Reality
    Clint Pepper, Ph.D., Director of MAST Technology at Capsugel, explains the Modular Automated Sampling Technology platform.
  15. New Ventures in the Microbiome

    Predictions look bright for the microbiome market.

  16. Changes in the Biopharma Industry: from Minor to Major Evolution
    Real-world evidence and digital technologies are creating new medical solutions that will change the way diseases are detected, treated and prevented.
  17. China to Accelerate Review of 48 Foreign Drugs

    China’s FDA publishes a list of drugs approved in the US, EU and Japan needed in the country.

  18. Artios Pharma Receives $84 million in Series B Funding

    The DNA Damage Response (DDR) company is developing innovative treatments for cancer.

  19. Mallinckrodt Forms Collaborative Research Partnership with Washington University in St. Louis
    Mallinckrodt to fund up to $10 million in collaborative research programs over five years to focus on rare diseases.
  20. Alteogen Gets FDA Approval for Orphan Drug Designation with an Antibody-Drug Conjugate for Gastric Cancer

    Alteogen Inc. has received an approval for orphan drug designation from the US Food and Drug Administration (FDA) with one of its assets (ALT-P7) for gastric cancer.

THE ROAD TO BIO: THE EXTENDED STORY
View All

Road To BIO: Coming Soon To Your Screen Q4 2018
The Road to BIO in Review
The Road To BIO: Day 12 California
The Road To BIO: Day 11 Arizona /// California
The Road To BIO: Day 10 Texas /// Arizona
The Road To BIO: Day 9 Texas
The Road To BIO: Day 8 Texas
The Road To BIO: Day 7 Mississippi /// Texas
The Road To BIO: Day 6 Georgia /// Mississippi
The Road To BIO: Day 5 South Carolina /// Georgia
The Road To BIO: Day 4 Tennessee /// South Carolina
The Road To BIO: Day 3 Pennsylvania /// Tennessee
The Road To BIO: Day 2 New York /// Pennsylvania
For Your Listening Pleasure
The full story of this epic journey can be experienced as an audiobook. Listen to the story behind the story – the characters, the challenges, and all 12 days of the Road To BIO.
Nice Insight Awareness/Perception Scorecard

Research. Compare. Contact. Find the Ideal Partner.

Customer Awareness (CA) describes a buyer’s knowledge of your offering, while Customer Perception (CP) describes how a buyer rates your company based on that knowledge. Nice Insight’s CA/CP scorecard allows you to measure market awareness and perception of you and your industry peers based on acknowledged outsourcing drivers.

  1. Search by company type, region, market segment and services.
  2. Select up to 5 companies to compare.
  3. View CA & CP performance scores against industry benchmark ratings.
SEARCH COMPANIES
Acquisition

Quethera Acquired by Astellas Pharma

Aug 14, 2018 12:21:54 PM PAO-M08-18-NI-018
Facility

Groundbreaking for Amgen in Rhode Island

Aug 14, 2018 12:17:45 PM PAO-M08-18-NI-017
Breakthrough Therapy

Xolair Gets Breakthrough Therapy Designation from US FDA for Treatment of Food Allergies

Aug 14, 2018 12:13:08 PM PAO-M08-18-NI-016
Business

Perrigo to Divest Its Prescription Drug Business

Aug 14, 2018 12:09:57 PM PAO-M08-18-NI-015
Investment

Artios Pharma Receives $84 million in Series B Funding

Aug 14, 2018 12:07:40 PM PAO-M08-18-NI-014
Regulatory

China to Accelerate Review of 48 Foreign Drugs

Aug 14, 2018 12:04:37 PM PAO-M08-18-NI-013
Market Intelligence

Forces Driving Growth in the U.S. Surgical Microscopes Market

Aug 9, 2018 3:58:58 PM PAO-08-18-CL-001
Acquisition

Intertek Groups Expands Offerings with the Acquisition of Alchemy Systems

Aug 9, 2018 1:12:27 PM PAO-M08-18-NI-012
Biologics

New Method Developed for Stereoselective Synthesis of Biologic Drug Substances

Aug 8, 2018 2:11:08 PM PAO-M08-18-NI-011
China

Big Pharma Companies Taking New Drugs to China First

Aug 8, 2018 2:03:21 PM PAO-M08-18-NI-010
CRO

From Internal Lab to External Service Provider

Aug 8, 2018 1:57:27 PM PAO-M08-18-NI-009
Drug Delivery

Exosomes Explored as New Option in Drug Delivery

Aug 7, 2018 3:33:40 PM PAO-M08-18-NI-008
Microbiome

New Collaboration Targets Drug Development Using the Gut Microbiome

Aug 7, 2018 3:12:17 PM PAO-M08-18-NI-007
Columns

Nice Insight Overview

Changes in the  Biopharma Industry: from Minor to Major Evolution
New technologies such as gene editing are leading to the development of even more advanced, targeted medicines.

The Next-Generation Player

Addressing Development Challenges for Complex Biologic Drug Candidates
At Lonza, we are constantly looking to reduce the development timeline, giving our customers more control over their projects.


Karen Fallen, Vice President, Business Unit Head of Clinical Development & Manufacturing Lonza Pharma & Biotech

M+A Column

Inside Mergers & Acquisitions
Kevin Bottomley Partner, Results Healthcare
Deals in the pharmaceutical industry are an important mechanism of acquiring innovation, business and efficiency.

Nice Insight Overview

Doping: Famous Cases, Substances and Values in Sports

Marc Technow, Nice Insight